Page 2 - Janet Dorling News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Janet dorling. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Janet Dorling Today - Breaking & Trending Today

Jennison Associates LLC Increases Holdings in CymaBay Therapeutics, Inc. (NASDAQ:CBAY)

Jennison Associates LLC lifted its holdings in shares of CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Free Report) by 12.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 3,992,711 shares of the biopharmaceutical company’s stock after buying an additional 437,437 shares during the quarter. Jennison Associates LLC’s holdings in CymaBay Therapeutics were worth $94,308,000 at […] ....

Piper Sandler , Raymond James , Janet Dorling , Jennison Associates , Clarius Group , Securities Exchange Commission , International Assets Investment Management , Calamos Advisors , Cymabay Therapeutics Inc , Holdings Channel , Allspring Global Investments Holdings , Wetzel Investment Advisors Inc , Cymabay Therapeutics , Free Report , Investment Advisors , Global Investments Holdings , Bay Therapeutics , Get Free Report , Director Janet Dorling , Exchange Commission , Visit Holdingschannel , Cymabay Therapeutics Daily , Nasdaq Cbay , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Receives Average Recommendation of "Hold" from Analysts

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Receives Average Recommendation of "Hold" from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

William Blair , Janet Dorling , Raymond James , Charles Mcwherter , Vanguard Group Inc , Pricet Rowe Associates Inc , Blackrock Inc , Avoro Capital Advisors , Cymabay Therapeutics Inc , Cymabay Therapeutics , Get Free Report , Marketbeat Ratings , Lifesci Capital , Director Janet Dorling , Capital Advisors , Pricet Rowe Associates , Bay Therapeutics , Get Free , Cymabay Therapeutics Daily ,

CymaBay Therapeutics (NASDAQ:CBAY) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of CymaBay Therapeutics (NASDAQ:CBAY – Free Report) in a report released on Wednesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Several other research analysts have also commented on CBAY. Piper Sandler reaffirmed a neutral rating and issued a $32.50 price target (down from $33.00) on shares […] ....

New York , United States , Piper Sandler , Janet Dorling , Raymond James , Pault Quinlan , Jennison Associates , Cantor Fitzgerald , Cymabay Therapeutics Inc , York State Common Retirement Fund , Emerald Mutual Fund Advisers , Emerald Advisers , Cymabay Therapeutics , Free Report , Bay Therapeutics , Get Free Report , General Counsel Paul , Director Janet Dorling , Mutual Fund Advisers Trust , Cymabay Therapeutics Daily ,

CymaBay Therapeutics (NASDAQ:CBAY) Now Covered by Analysts at StockNews.com

CymaBay Therapeutics (NASDAQ:CBAY) Now Covered by Analysts at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

William Blair , Charles Mcwherter , Janet Dorling , Piper Sandler , Strategic Blueprint , Harvest Fund Management Co , Chartwell Investment Partners , Securities Exchange Commission , Cymabay Therapeutics Inc , Alps Advisors Inc , Mirae Asset Global Investments Co , Cymabay Therapeutics , Free Report , Bay Therapeutics , Get Free Report , Director Janet Dorling , Exchange Commission , Investment Partners , Asset Global Investments , Harvest Fund Management , Cymabay Therapeutics Daily ,

Assenagon Asset Management S.A. Invests $17.63 Million in CymaBay Therapeutics, Inc. (NASDAQ:CBAY)

Assenagon Asset Management S.A. purchased a new position in shares of CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 746,353 shares of the biopharmaceutical company’s stock, valued at approximately $17,629,000. Assenagon Asset Management […] ....

New York , United States , Daniel Menold , Piper Sandler , Janet Dorling , Emerald Advisers , Jennison Associates , Emerald Mutual Fund Advisers , Cymabay Therapeutics Inc , York State Common Retirement Fund , Exchange Commission , Cymabay Therapeutics , Free Report , Mutual Fund Advisers Trust , Seven Eight Capital , Director Janet Dorling , Bay Therapeutics , Get Free Report , Lifesci Capital , Cymabay Therapeutics Daily , Nasdaq Cbay , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,